11/18/2022 8:15:47 AM
Novavax Nuvaxovid COVID-19 Vaccine Receives Expanded Authorization In Canada As Booster In Adults
11/9/2022 9:32:04 AM
Novavax Nuvaxovid COVID-19 Vaccine Authorized In U.K For Use As Booster In Adults
11/8/2022 4:05:05 PM
Novavax Q3 Loss/share $2.15 Vs. Loss $4.31 Year Ago
11/8/2022 8:04:23 AM
Novavax Says Phase 3 COVID-19 Omicron Trial Supports Continued And Future Use Of Its Prototype Vaccine As Booster
11/1/2022 4:31:40 PM
Novavax Appoints Rick Rodgers To Board Of Directors
10/19/2022 11:04:31 AM
FDA Grants Emergency Use Authorization For Novavax COVID-19 Vaccine, Adjuvanted As Booster For Adults
10/13/2022 8:32:54 AM
Novavax COVID-19-Influenza Combination Vaccine Candidate Induced Antibody And T-Cell Responses Against SARS-CoV-2
10/12/2022 8:31:54 AM
Novavax : COVID-19 Vaccine Data Support Homologous And Heterologous Boosting And Suggest Benefit Against Variants
9/27/2022 8:30:52 AM
Novavax Makes 1 Mln Doses Of Nuvaxovid Available For Use In The United Kingdom
9/16/2022 8:16:34 AM
Novavax Nuvaxovid COVID-19 Vaccine Gets Expanded Emergency Use Authorization In Taiwan For Use In Adolescents